EMBC (STOCKS)
Embecta Corp. Common Stock
$3.130000
+0.030000 (+0.97%)
Prev close: $3.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Devdatt Kurdikar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $185.70M
- Employees
- 2,100
- P/E (TTM)
- 1.63
- P/B (TTM)
- -0.29
- Dividend Yield
- 1,483.87%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q2)
|
$0.27 | $0.43 | -0.1559 | -36.60% |
|
Dec 2025 (Q1)
|
$0.71 | $0.68 | +0.0266 | +3.89% |
|
Sep 2025 (Q4)
|
$0.50 | $0.55 | -0.0474 | -8.66% |
|
Jun 2025 (Q3)
|
$1.12 | $0.79 | +0.3295 | +41.68% |
Financial Statements
| Revenues | $1.04B |
| Benefits Costs and Expenses | $872.90M |
| Cost Of Revenue | $397.40M |
| Costs And Expenses | $872.90M |
| Gross Profit | $645.10M |
| Nonoperating Income/Loss | $200.00K |
| Operating Expenses | $376.30M |
| Selling, General, and Administrative Expenses | $325.10M |
| Research and Development | $19.00M |
| Other Operating Expenses | $32.20M |
| Operating Income/Loss | $268.80M |
| Income/Loss From Continuing Operations After Tax | $111.90M |
| Income/Loss From Continuing Operations Before Tax | $169.60M |
| Income Tax Expense/Benefit | $57.70M |
| Income Tax Expense/Benefit, Deferred | $21.80M |
| Net Income/Loss | $111.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $111.90M |
| Net Income/Loss Available To Common Stockholders, Basic | $111.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.92 |
| Diluted Earnings Per Share | $1.89 |
| Basic Average Shares | 176,655,000 |
| Diluted Average Shares | 177,278,000 |
| Assets | $1.03B |
| Current Assets | $608.10M |
| Inventory | $192.60M |
| Other Current Assets | $415.50M |
| Noncurrent Assets | $421.20M |
| Liabilities | $1.66B |
| Current Liabilities | $247.30M |
| Wages | $34.60M |
| Other Current Liabilities | $212.70M |
| Noncurrent Liabilities | $1.41B |
| Equity | -$626.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$626.10M |
| Liabilities And Equity | $1.03B |
| Net Cash Flow From Operating Activities | $213.50M |
| Net Cash Flow From Operating Activities, Continuing | $213.50M |
| Net Cash Flow From Investing Activities | $1.30M |
| Net Cash Flow From Investing Activities, Continuing | $1.30M |
| Net Cash Flow From Financing Activities | -$237.30M |
| Net Cash Flow From Financing Activities, Continuing | -$237.30M |
| Net Cash Flow | -$22.50M |
| Net Cash Flow, Continuing | -$22.50M |
| Comprehensive Income/Loss | $129.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $129.00M |
| Other Comprehensive Income/Loss | $129.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $17.10M |